Good news about the treatment of Alzheimer’s disease is hard to find. However, new breakthrough research is hailed as the “best news” in dementia research for 25 years and a potential “game changer” for people with the disease. In a preliminary trial a bioengineered medication called aducanumab has demonstrated the ability to clear accumulations of beta-amyloid proteins—a hallmark of Alzheimer’s—from the brain. Compared with subjects receiving a placebo medication, those who got monthly infusions of aducanumab in high doses appeared to experience less progressive loss in mental function.
Experimental drug slows memory loss and halts Alzheimer’s decline
More of Today's Solutions
How kites and ancient design are replacing fuel in Antarctic exploration
BY THE OPTIMIST DAILY EDITORIAL TEAM The last time a team completed a comparable crossing of Antarctica's interior, they burned through roughly 170,000 liters ...
Read MoreIs this nut the most underrated sleepy-time snack? Here’s what the slee...
BY THE OPTIMIST DAILY EDITORIAL TEAM You're doing everything right at bedtime: you stay away from screens after nine, take a soothing dark shower, ...
Read MoreEarthworms: a natural solution to farms’ wastewater
Royal Dairy in Royal City, Washington has a problem that's common to dairy farms. The hundreds of millions of gallons of water used by ...
Read MoreHow Swim Sista Swim Is Redefining Water Confidence for Black Women in the UK
BY THE OPTIMIST DAILY EDITORIAL TEAM Language, Identity & Belonging Welcome to the second week of The Optimist Daily’s Annual Local Changemakers series. Each ...
Read More
